Hundreds more people with suspected kidney cancer should have a biopsy to help confirm their diagnosis sooner and treat their disease more effectively, according to new draft guidelines from NICE.

Durvalumab, also known as Imfinzi and made by AstraZeneca, is recommended in final draft guidance for adults with limited-stage small cell lung cancer (SCLC). This is where the cancer is contained in ...